Patent application number | Description | Published |
20120066596 | System And Method For Video Communication On Mobile Devices - A video teleconferencing system which allows a mobile device to conduct teleconferences over fixed and mobile packet networks with end points with other mobile devices or a personal computer. The mobile device includes a user interface that displays a video image associated with a first participant. A selectable user interface element corresponding to a second participant video image may be displayed on the user interface and in response to selection of the selectable user interface element, a video image associated with the second participant may be displayed. | 03-15-2012 |
20150103885 | REAL TIME IP VIDEO TRANSMISSION WITH HIGH RESILIENCE TO NETWORK ERRORS - A method and system related to video transmission to increase resiliency to network errors, such as packet loss. Packet loss can lead to low quality or broken audio, pixilation, image freeze, and other distortions of a video signal. The system and method utilizes packet retransmission and FEC in combination to increase error recovery. Further, the system and method takes into account unique data source characteristics in order increase resilience to network error while minimizing overhead. Finally, the system and method takes into account network conditions, especially in networks with heterogeneous conditions, by separating uplinks and downlinks and adjusting to each individual link in order to provide optimal protection for each link. | 04-16-2015 |
20150130952 | SYSTEM AND METHOD FOR ESTIMATING QUALITY OF VIDEO WITH FRAME FREEZING ARTIFACTS - A method and system that assesses video quality of transmitted video packet signals suffering from packet loss and delay. This packet loss and delay can create freeze events, which are observed as a jerkiness while viewing the video. The system and method compares the frames in a video transmission to determine freeze events; extracts a set of features from the locations of the freeze events and decoded video frames; and maps the set of features into a video quality score using a neural network. The video quality score provides an assessment of the effects of irregular frame freezes due to packet loss or delay on the quality of the video. | 05-14-2015 |
Patent application number | Description | Published |
20090209544 | Aminotetrahydropyrans as Dipeptidyl Peptidase-IV Inhibitors for the Treatment or Prevention of Diabetes - The present invention is directed to novel substituted aminotetrahydropyrans of structural formula I which are inhibitors of the dipeptidyl peptidase-IV enzyme and which are useful in the treatment or prevention of diseases in which the dipeptidyl peptidase-IV enzyme is involved, such as diabetes and particularly Type 2 diabetes. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which the dipeptidyl peptidase-IV enzyme is involved. | 08-20-2009 |
20100324054 | AMINOTETRAHYDROPYRANS AS DIPEPTIDYL PEPTIDASE-IV INHIBITORS FOR THE TREATMENT OR PREVENTION OF DIABETES - The present invention is directed to novel substituted aminotetrahydropyrans of structural formula I which are inhibitors of the dipeptidyl peptidase-IV enzyme and which are useful in the treatment or prevention of diseases in which the dipeptidyl peptidase-IV enzyme is involved, such as diabetes and particularly Type 2 diabetes. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which the dipeptidyl peptidase-IV enzyme is involved. | 12-23-2010 |
20110224195 | HETEROCYCLIC COMPOUNDS AS DIPEPTIDYL PEPTIDASE-IV INHIBITORS FOR THE TREATMENT OR PREVENTION OF DIABETES - The present invention is directed to substituted six-membered heterocyclic compounds of structural formula (I) which are inhibitors of the dipeptidyl peptidase-IV enzyme and which are useful in the treatment or prevention of diseases in which the dipeptidyl peptidase-IV enzyme is involved, such as obesity and diabetes, particularly Type 2 diabetes. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which the dipeptidyl peptidase-IV enzyme is involved. | 09-15-2011 |
20120149683 | SUBSTITUTED AMINOPIPERIDINES AS DIPEPTIDYL PEPTIDASE-IV INHIBITORS FOR THE TREATMENT OF DIABETES - The present invention is directed to novel substituted aminopiperidines of structural formula I which are inhibitors of the dipeptidyl peptidase-IV enzyme and which are useful in the treatment or prevention of diseases in which the dipeptidyl peptidase-ÏV enzyme is involved, such as diabetes and particularly Type 2 diabetes. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which the dipeptidyl peptidase-IV enzyme is involved. | 06-14-2012 |
20120149734 | AMINOTETRAHYDROPYRANS AS DIPEPTIDYL PEPTIDASE-IV INHIBITORS FOR THE TREATMENT OR PREVENTION OF DIABETES - The present invention is directed to novel substituted aminotetrahydropyrans of structural formula I which are inhibitors of the dipeptidyl peptidase-IV enzyme and which are useful in the treatment or prevention of diseases in which the dipeptidyl peptidase-IV enzyme is involved, such as diabetes and particularly Type 2 diabetes. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which the dipeptidyl peptidase-IV enzyme is involved. | 06-14-2012 |
20120277240 | SUBSTITUTED AMINOTETRAHYDROTHIOPYRANS AND DERIVATIVES THEREOF AS DIPEPTIDYL PEPTIDASE-IV INHIBITORS FOR THE TREATMENT OF DIABETES - The present invention is directed to novel substituted aminotetrahydrothiopyrans and derivatives thereof of structural formula (I) which are inhibitors of the dipeptidyl peptidase-IV enzyme and which are useful in the treatment or prevention of diseases in which the dipeptidyl peptidase-IV enzyme is involved, such as diabetes and particularly Type 2 diabetes. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which the dipeptidyl peptidase-IV enzyme is involved. | 11-01-2012 |
20130123237 | NOVEL CYCLIC AZABENZIMIDAZOLE DERIVATIVES USEFUL AS ANTI-DIABETIC AGENTS - Novel compounds of structural formula (I) are activators of AMP-protein kinase and are useful in the treatment, prevention and suppression of diseases mediated by the AMPK-activated protein kinase. The compounds of the present invention are useful in the treatment of Type 2 diabetes, hyperglycemia, metabolic syndrome, obesity, hypercholesterolemia, and hypertension. | 05-16-2013 |
20150197516 | NOVEL BENZIMIDAZOLE TETRAHYDROPYRAN DERIVATIVES - Novel compounds described herein are activators of AMP-protein kinase and may be useful in the treatment, prevention and suppression of diseases mediated by the AMPKactivated protein kinase. The compounds of the present invention may be useful in the treatment of Type 2 diabetes, hyperglycemia, metabolic syndrome, obesity, hypercholesterolemia, and hypertension. | 07-16-2015 |
20150203487 | NOVEL AZABENZIMIDAZOLE TETRAHYDROFURAN DERIVATIVES - Novel compounds of the structural formula (I) are activators of AMP-protein kinase and may be useful in the treatment, prevention and suppression of diseases mediated by the AMPK-activated protein kinase. The compounds of the present invention may be useful in the treatment of Type 2 diabetes, hyperglycemia, metabolic syndrome, obesity, hypercholesterolemia, and hypertension. | 07-23-2015 |
20150210685 | NOVEL AZABENZIMIDAZOLE TETRAHYDROPYRAN DERIVATIVES - Novel compounds of the structural formula (I) are activators of AMP-protein kinase and may be useful in the treatment, prevention and suppression of diseases mediated by the AMPKactivated protein kinase. The compounds of the present invention may be useful in the treatment of Type 2 diabetes, hyperglycemia, metabolic syndrome, obesity, hypercholesterolemia, and hypertension. | 07-30-2015 |
20150218149 | NOVEL BENZIMIDAZOLE TETRAHYDROFURAN DERIVATIVES - Novel compounds of the structural formula (I) are activators of AMP-protein kinase and may be useful in the treatment, prevention and suppression of diseases mediated by the AMPK-activated protein kinase. The compounds of the present invention may be useful in the treatment of Type 2 diabetes, hyperglycemia, metabolic syndrome, obesity, hypercholesterolemia, and hypertension. | 08-06-2015 |
20150218183 | NOVEL BENZIMIDAZOLE HEXAHYDROFURO[3,2-B]FURAN DERIVATIVES - The novel benzimidazole hexahydrofuro[3,2-B]furan derivatives of the present invention are activators of AMP-protein kinase and may be useful in the treatment, prevention and suppression of diseases mediated by the AMPK-activated protein kinase. The compounds of the present invention may be useful in the treatment of Type 2 diabetes, hyperglycemia, metabolic syndrome, obesity, hypercholesterolemia, and hypertension. | 08-06-2015 |
20150284411 | NOVEL AZABENZIMIDAZOLE HEXAHYDROFURO[E,2-B]FURAN DERIVATIVES - Novel compounds of the structural formula (I) are activators of AMP-protein kinase and may be useful in the treatment, prevention and suppression of diseases mediated by the AMPK activated protein kinase. The compounds of the present invention may be useful in the treatment of Type 2 diabetes, hyperglycemia, metabolic syndrome, obesity, hypercholesterolemia, and hypertension. | 10-08-2015 |
Patent application number | Description | Published |
20090015239 | Transmission Line Sensor - A system and method in which an overhead high voltage transmission line sensor system is able to measure one or more of temperature, current, and line sag for a conductor within a high voltage transmission line system. The sensor system may be able to clamp to a transmission conductor or splice, harvest power from the transmission line, and/or transmit data corresponding to measurements of current, temperature, and line sag. | 01-15-2009 |
20090086214 | ALIGNED EMBOSSED DIAPHRAGM BASED FIBER OPTIC SENSOR - The present invention is a diaphragm-fiber optic sensor (DFOS), interferometric sensor. This DFOS is based on the principles of Fabry-Perot and Michelson/Mach-Zehnder. The sensor is low cost and is designed with high efficiency, reliability, and Q-point stability, fabricated using MEMS (micro mechanic-electrical system) technology, and has demonstrated excellent performance. A DFOS according to the invention includes a cavity between two surfaces: a diaphragm made of silicon or other material with a rigid body (or boss) at the center and clamped along its edge, and the endface of a single mode optic fiber. By utilizing MEMS technology, the gap width between the diaphragm and the fiber endface is made accurately, ranging from 1 micron to 10 microns. To stabilize the Q-point of the DFOS when in use as an acoustic sensor, a system of microchannels is built in the structure of the diaphragm so that the pressure difference on two sides of the diaphragm is kept a constant, independent of the hydraulic pressure and/or low frequency noise when the device is inserted in liquid mediums. | 04-02-2009 |
Patent application number | Description | Published |
20080220076 | Active Agent Formulations, Methods of Making, and Methods of Use - Active agent compositions comprising active agent particles having an effective average particle size of less than 2000 nm, wherein the compositions comprise a particle sequestrant are disclosed. Compositions having an effective average particle size of less than 2000 nm, wherein the compositions comprise no added surfactants, phospholipids, or combinations thereof, are also disclosed. | 09-11-2008 |
20090074872 | Active Agent Formulations, Methods of Making, and Methods of Use - Stable fenofibrate suspensions are disclosed herein. A fenofibrate composition includes fenofibrate nanoparticles having an average particle size of less than 500 nm, and a particle sequestrant, wherein the average particle size of the nanoparticulate suspension changes by less than 50% after standing at room temperature for 21 or more days. | 03-19-2009 |
20090093548 | COLCHINE COMPOSITIONS AND METHODS - Stable ultrapure colchicine compositions comprising ultrapure colchicine and a pharmaceutically acceptable excipient are described. The compositions can be tablets. Methods for preparing such compositions and methods of use are also disclosed. Methods of treating gout flares with colchicine compositions are also disclosed. | 04-09-2009 |
20090170952 | COLCHICINE COMPOSITIONS AND METHODS - Stable ultrapure colchicine compositions comprising ultrapure colchicine and a pharmaceutically acceptable excipient are described. The compositions can be tablets. Methods for preparing such compositions and methods of use are also disclosed. Methods of treating gout flares with colchicine compositions are also disclosed. | 07-02-2009 |
20090215904 | COLCHICINE COMPOSITIONS AND METHODS - Stable ultrapure colchicine compositions comprising ultrapure colchicine and a pharmaceutically acceptable excipient are described. The compositions can be tablets. Methods for preparing such compositions and methods of use are also disclosed. Methods of treating gout flares with colchicine compositions are also disclosed. | 08-27-2009 |
20090298948 | COLCHICINE COMPOSITIONS AND METHODS - Stable ultrapure colchicine compositions comprising ultrapure colchicine and a pharmaceutically acceptable excipient are described. The compositions can be tablets. Methods for preparing such compositions and methods of use are also disclosed. Methods of treating gout flares with colchicine compositions are also disclosed. | 12-03-2009 |
20100159010 | Active Agent Formulations, Methods of Making, and Methods of Use - An active agent composition includes particles containing a water-insoluble active agent or an active agent with a significant food effect; and a ternary amine polymer having both hydrophobic (meth)acrylate units and acid-soluble (meth)acrylate units, and an acidifying agent; wherein upon ingestion by a human subject, the acidifying agent facilitates the dissolution of the ternary amine polymer in the gastrointestinal tract. | 06-24-2010 |
20110263716 | COLCHINE COMPOSITIONS AND METHODS - Stable ultrapure colchicine compositions comprising ultrapure colchicine and a pharmaceutically acceptable excipient are described. The compositions can be tablets. Methods for preparing such compositions and methods of use are also disclosed. Methods of treating gout flares with colchicine compositions are also disclosed. | 10-27-2011 |
20120328677 | Active Agent Formulations, Methods of Making, and Methods of Use - An active agent composition includes particles containing a water-insoluble active agent or an active agent with a significant food effect; and a ternary amine polymer having both hydrophobic (meth)acrylate units and acid-soluble (meth)acrylate units, and an acidifying agent; wherein upon ingestion by a human subject, the acidifying agent facilitates the dissolution of the ternary amine polymer in the gastrointestinal tract. | 12-27-2012 |
20140037550 | COLCHICINE COMPOSITIONS AND METHODS - Stable ultrapure colchicine compositions comprising ultrapure colchicine and a pharmaceutically acceptable excipient are described. The compositions can be tablets. Methods for preparing such compositions and methods of use are also disclosed. Methods of treating gout flares with colchicine compositions are also disclosed. | 02-06-2014 |
Patent application number | Description | Published |
20090131528 | SALT - The invention relates to a new salt of aliskiren, the respective production and usage, and pharmaceutical preparations containing such a salt. | 05-21-2009 |
20090156585 | ORGANIC COMPOUNDS - A specific combination, linked pro-drug or a compound of an angiotensin receptor antagonist and a NEPi are used in the treatment of hypertension. | 06-18-2009 |
20090163478 | Salts and Crystal Modifications Thereof - The invention relates to salts of 1-(2-Fluoro-phenyl)-3-(2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-urea and crystalline forms thereof, their production and usage, and pharmaceutical preparations containing such salts and crystalline forms. | 06-25-2009 |
20110171159 | Glycoside Derivatives and Uses Thereof - This invention relates to compounds represented by formula (I): | 07-14-2011 |
20120178680 | GLYCOSIDE DERIVATIVES AND USES THEREOF - This invention relates to compounds represented by formula (I): | 07-12-2012 |
20130017993 | GLYCOSIDE DERIVATIVES AND USES THEREOF - This invention relates to compounds represented by formula (I): | 01-17-2013 |
20130274279 | CRYSTALLINE FORMS OF 5-CHLORO-N2-(2-ISOPROPOXY-5-METHYL-4-PIPERIDIN-4-YL-PHENYL)-N4-[2-(PROPAN- E-2-SULFONYL)-PHENYL]-PYRIMIDINE-2, 4-DIAMINE - The present invention describes specific crystalline forms of 5-chloro-N-(2-isopropoxy-5-methyl-4-(piperidin-4-ylphenyl)-N-2-(isopropylsulfonyl)phenyl)-2,4-diamine. The present invention further relates to methods for preparing said crystalline forms, pharmaceutical compositions comprising said crystalline forms, and methods of using said crystalline forms and pharmaceutical compositions to treat disease. | 10-17-2013 |
20140093570 | Solid Oral Formulations and Crystalline Forms of an Inhibitor of Apoptosis Protein - The present disclosure relates to crystalline form of (S)—N—((S)-1-cyclohexyl-2-{(S)-2-[4-(4-fluorobenzoyl)-thiazol-2-yl]-pyrrolidin-1-yl}-2-oxo-ethyl)-2-methylamino-propionamide, salts and hydrates thereof. This disclosure also relates to solid oral formulation of (S)—N—((S)-1-cyclohexyl-2-{(S)-2-[4-(4-fluoro-benzoyl)-thiazol-2-yl]-pyrrolidin-1-yl}-2-oxo-ethyl)-2-methylamino-propionamide, pharmaceutically acceptable salts, solvates (including hydrates) thereof, as well as methods of treatment using the same. | 04-03-2014 |
20140274921 | GLYCOSIDE DERIVATIVES AND USES THEREOF - This invention relates to compounds represented by formula (I): | 09-18-2014 |
20150141354 | GLYCOSIDE DERIVATIVES AND USES THEREOF - This invention relates to compounds represented by formula (I): | 05-21-2015 |
Patent application number | Description | Published |
20080199415 | COMPOSITIONS CONTAINING A BIMODAL FILM FORMER AND CROSS-LINKED STARCH - The invention relates to compositions containing (a) at least one bimodal film former; and (b) at least one cross-linked starch as well as to methods of using such compositions and kits containing such compositions. | 08-21-2008 |
20090136439 | COSMETIC COMPOSITION CAPABLE OF IMPARTING EXCEPTIONAL CURL-RETENTION PROPERTIES - The present invention is directed to a composition and method of making-up eyelashes involving applying onto the lashes a cosmetic composition containing: (a) at least one bimodal polymer having both anionic and cationic functionalities; (b) an aqueous microdispersion of at least one wax; (c) at least one coloring agent; (d) a physiologically suitable medium, and (e) optionally, an aqueous dispersion of at least one film-forming polymer, wherein the cosmetic composition has an average particle size of less than about 10 microns. | 05-28-2009 |
20090169501 | MASCARA CONTAINING A SUGAR SILICONE SURFACTANT - The invention relates to a mascara composition comprising at least one sugar silicone surfactant, as well as to methods of making and using such mascaras. | 07-02-2009 |
20090252698 | EMULSION COMPOSITIONS FOR EYELASHES - The invention relates to emulsion compositions for application to eyelashes containing at least one surfactant comprising silicone, hydrocarbon and glycerol group(s), as well as to methods of applying such compositions to eyelashes and kits containing such compositions. | 10-08-2009 |
20100043819 | COMPOSITIONS CONTAINING STIMULUS SENSITIVE COLORANT - The invention relates to compositions containing stimulus sensitive colorant as well as to methods of applying such compositions to keratin materials and kits containing such compositions. | 02-25-2010 |
20110086000 | NOVEL SKIN PEEL COMPOSITION IN MASQUE FORM - The present invention is directed to a method of reducing the appearance of skin changes associated with intrinsic and/or extrinsic aging, involving the steps of: (a) providing a first composition containing: (i) from about 20 to about 50% by weight of at least one hydroxy acid; (ii) optionally, from about 1 to about 15% by weight of at least one weak organic acid; and (iii) remainder, to 100%, water; (b) providing a second composition containing: (iv) from about 20 to about 50% by weight of L-ascorbic acid powder; (v) optionally, from about 1 to about 10% by weight of an extract of | 04-14-2011 |
20110300092 | MASCARAS OBTAINED VIA MULTI-PHASE PRODUCT - Disclosed is a multi-phase mascara product, including a first container having disposed therein a first phase comprising a wax, a second container having disposed therein a second phase comprising a film forming polymer, and a third container into which relative amounts of said first and second phases may be introduced, wherein upon mixing of the first and second phases, the third container comprises the wax, the film-forming polymer, a solvent and a thickener, wherein if the solvent and thickener are oil-soluble, they are present in the first phase, and if the solvent is aqueous and the thickener is water-soluble, they are present in the second phase. Also disclosed are methods of producing the mascara, by mixing relative amounts of the phases into a separate container. Further disclosed are methods of making up the eye lashes by application of the mascara. | 12-08-2011 |
Patent application number | Description | Published |
20110076961 | Systems and Methods for Controlling the Second Order Intercept Point of Receivers - In accordance with some embodiments, methods for controlling the second order intercept point in a receiver are provided, the methods comprising: generating an amplitude modulated test tone; causing the test tone to be received by a receiver; determining a characteristic of a second order intercept point of the receiver based on the received test tone; and based on the characteristic, adjusting a parameter of the receiver. In accordance with some embodiments, systems for controlling the second order intercept point in a receiver are provided, the systems comprising: a test tone generator that generates an amplitude modulated test tone; a receiver that receives the test tone; a correlator that determines a characteristic of a second order intercept point of the receiver based on the received test tone; and digital logic that, based on the characteristic, adjusts a parameter of the receiver. | 03-31-2011 |
20120142280 | LOW COST, ACTIVE ANTENNA ARRAYS - A transmitter system including: a bidirectional signaling (BDS) network having first and second networks for carrying first and second carrier signals, and having a set of n phase synchronous location pairs (a | 06-07-2012 |
20120258754 | TECHNIQUES FOR ACHIEVING HIGH AVERAGE SPECTRUM EFFICIENCY IN A WIRELESS SYSTEM - Techniques for achieving high average spectrum efficiency in a wireless system are disclosed. In one particular embodiment, the techniques may be realized as a method of communicating with a wireless station comprising defining a plurality of beams to be generated by a beam-forming device, defining a set of beam groups wherein each beam group is a different subset of beams of the plurality of beams; repeatedly cycling through the set of beam groups by sequentially generating each group of beams among the set of beam groups; identifying a beam group among the set of beam groups which yields a best communication link with a wireless station; and scheduling communications with the wireless station to occur via the identified beam group when the identified beam group is being generated. | 10-11-2012 |
20150056937 | SYSTEMS AND METHODS FOR CONTROLLING THE SECOND ORDER INTERCEPT POINT OF RECEIVERS - In accordance with some embodiments, methods for controlling the second order intercept point in a receiver are provided, the methods comprising: generating an amplitude modulated test tone; causing the test tone to be received by a receiver; determining a characteristic of a second order intercept point of the receiver based on the received test tone; and based on the characteristic, adjusting a parameter of the receiver. In accordance with some embodiments, systems for controlling the second order intercept point in as receiver are provided, the systems comprising: a test tone generator that generates an amplitude modulated test tone; a receiver that receives the test tone; a correlator that determines a characteristic of a second order intercept point of the receiver based on the received test tone; and digital logic that, based on the characteristic, adjusts a parameter of the receiver. | 02-26-2015 |